For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Shuchita Kaila, PhD
Advertisement
Articles by Shuchita Kaila, PhD
Advertisement
Latest Updated Articles
- Impact of Initial Days' Supply of Angiotensin II Receptor Blockers
February 17th 2016
Advertisement
Advertisement
Trending on Pharmacy Times
1
Single-Center Experience With Vorasidenib in Patients With Grade 3 or 4 IDH-Mutant Gliomas
2
McKesson ideaShare 2026: Why Automation and AI Are Reshaping the Dispensing Experience
3
Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma
4
The Human Element: Building Relationships and Empathy in a Busy Pharmacy
5